Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care.
about
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsAnti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma.A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumorsInitial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma.
P2860
Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Generation of CAR T cells for ...... glioblastoma standard of care.
@ast
Generation of CAR T cells for ...... glioblastoma standard of care.
@en
type
label
Generation of CAR T cells for ...... glioblastoma standard of care.
@ast
Generation of CAR T cells for ...... glioblastoma standard of care.
@en
prefLabel
Generation of CAR T cells for ...... glioblastoma standard of care.
@ast
Generation of CAR T cells for ...... glioblastoma standard of care.
@en
P2093
P2860
P356
P1476
Generation of CAR T cells for ...... glioblastoma standard of care
@en
P2093
Carter M Suryadevara
David Snyder
Katherine Riccione
Luis Sanchez-Perez
P2860
P356
10.3791/52397
P50
P577
2015-02-16T00:00:00Z